ArticleMolecular biology of the cell2026
Systematic evaluation of tools for auxin-inducible protein degradation in budding yeast.
Article in Molecular biology of the cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A role for nucleosome remodellers during resection of deprotected telomeres in yeast.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The auxin system for inducible protein degradation is a powerful tool to investigate protein function. It consists of a degron fused to a target protein, an auxin-related ligand that binds to the degron, and a receptor that recognizes the auxin-bound degron and mediates proteasomal degradation of the target protein. Variants of all system components are available, and we here test three degrons, three auxins and three degron receptors to identify optimal combinations of these variants in budding yeast. We show that the degrons mIAA7 or AID* together with adamantyl-auxin and the degron receptor OsTIR1(F74G) allow particularly rapid and extensive degradation. Basal degradation in the absence of auxin is generally low and can be minimized further by inducible expression of OsTIR1(F74G). Moreover, we demonstrate that the remarkable efficiency of this system makes it competitive with established chemical inhibitors, such as tunicamycin and MG132, and with temperature-sensitive conditional alleles. These findings will aid the effective application of the auxin system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.